World Cup gold medallist Lakshay returns positive stanozolol test

Lakshay, who teamed with Ujjwal Singh to capture the lightweight double sculls gold at World Cup III in Switzerland last month, has tested positive for stanozolol. The adverse analytical finding came from a sample taken in Pune on May 25.

The pair’s triumph at World Cup III in Switzerland last month brought them international attention, with Lakshay named alongside Ujjwal Singh as the gold-medal crew in the lightweight double sculls. A sample collected from Lakshay in Pune on May 25 has since registered an adverse result for the anabolic agent stanozolol. This development links his recent on-water success with the outcome of the sample collected in India.

Testing authorities reported that the sample taken on May 25 in Pune returned a positive result for stanozolol. The presence of that substance in the analysed specimen is the specific basis for the failed dope test. The date and location of collection are central to the timeline connecting the sample to the athlete.

Lakshay’s gold at World Cup III came in partnership with Ujjwal Singh in the lightweight double sculls event, a victory that occurred last month in Switzerland. The achievement was the most recent major result recorded by the duo prior to the adverse analytical finding. The two-rower combination is named in reports relating to that success.

The positive test result for stanozolol and the earlier World Cup III gold are the two established facts reported in this case. The sample’s collection in Pune on May 25 and the identification of stanozolol are the specific details released concerning the failed test. No additional information about subsequent procedures or rulings has been included in the report.

The confirmed positive test links Lakshay’s May 25 sample from Pune to an adverse analytical finding for stanozolol, following the lightweight double sculls gold he won with Ujjwal Singh at World Cup III in Switzerland last month. Further updates would depend on any official communications that follow the testing outcome.